This webinar will explore the applications of Dynamic Light Scattering (DLS) and Electrophoretic Light Scattering (ELS) in the pharmaceutical industry.
The experts will discuss how these techniques enhance drug formulation, stability, and delivery and improve the quality and efficacy of pharmaceutical products.
Key Takeaways:
- Understanding the fundamentals of Dynamic Light Scattering (DLS) and Electrophoretic Light Scattering (ELS)
- How particle size distribution and zeta potential impact pharmaceutical formulations and stability
- Utilizing DLS and ELS to enhance drug delivery systems and improve pharmaceutical quality
- Comprehensive understanding of BeNano’s advanced measurement capabilities for pharmaceutical applications.
- Real-world case studies demonstrating BeNano’s applications in LNP, proteins, micelles, microemulsions, drug carriers, and Ag nanoparticles.
Watch the webinar teaser below:
Join Our Upcoming Webinar | Pharma Characterization with Light Scattering
Your Webinar Speakers:
![](https://d12oja0ew7x0i8.cloudfront.net/images/webinars/ImageForWebinars_875_17211294983328280.png)
Dr. John F. Miller, PhD is the inventor of Phase Analysis Light Scattering (PALS). He received his PhD in Colloid/Physical Chemistry from the University of Bristol.
With three decades of experience as a formulation scientist in the pharmaceutical industry, Dr. Miller has been working on colloid science and light scattering techniques.
![](https://d12oja0ew7x0i8.cloudfront.net/images/webinars/ImageForWebinars_875_1721047419702361.png)
Zhibin Guo, MS is a Senior Application Scientist at Bettersize Instruments. He received his master's degree in pharmaceutical synthesis from Seoul National University.
Since joining Bettersize, he has focused on application research in nanoparticle analysis and the synthesis and characterization of drug delivery systems using light scattering techniques.
Who Should Attend?
This webinar will benefit beginners and professionals in research, development, processing or quality control who acquire understanding of comprehensive pharma characterization or who want to refresh and expand existing knowledge. Furthermore, those who are looking for suggestions for further possible uses of particle size characterization as well as stability of pharmaceutical suspensions should attend this webinar.